Treatment of motility disorders with a GnRH analog

Details Treatment of motility disorders with a GnRH analog Treatment of motility disorders with a GnRH analog

1991-08-14

1992-11-24

Cashion, Jr., Merrell C.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

530330, 530328, A61K 3700, A61K 3702, C07K 500, C07K 700

Patent

active

051661926

ABSTRACT:
A treatment to alleviate the debilitating symptoms of Motility Disorders, including the Functional Bowel Diseases. Treatment of patients with analogs of GnRH signficantly reduces or elminates the symptoms of Motility Disorders, including Functional Bowel Disease.

REFERENCES:
patent: 4229438 (1980-10-01), Fujino et al.
patent: 4410514 (1983-10-01), Vale, Jr. et al.
patent: 4552764 (1985-11-01), Goodman et al.
patent: 4569927 (1986-02-01), Rivier et al.
Mathias, Johr R., Chemical Abstracts, CA 114(21):199692c.
Valdes et al., Chemical Abstracts, CA 114(9):75352x.
Howland et al., Chemical Abstracts, CA 93(3):19872c.

Affiliated with

Also associated with

Rating

Treatment of motility disorders with a GnRH analog does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of motility disorders with a GnRH analog, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of motility disorders with a GnRH analog will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-921989